Neumora Therapeutics, Inc. - Common Stock, $0.0001 par value (NMRA)

Historical Holders from Q3 2023 to Q3 2025

Symbol
NMRA on Nasdaq
CUSIP
640979100
Type / Class
Equity / Common Stock, $0.0001 par value
Shares outstanding
164M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
50.7M
Holdings value
$92.3M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
92
Number of buys
30
Number of sells
-57
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Neumora Therapeutics, Inc. - Common Stock, $0.0001 par value (NMRA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARCH Venture Fund XII, L.P. 20.7% $61.8M 34M Kristina Burow Oct 27, 2025
K2 HealthVentures Equity Trust LLC 6.6% $7.75M 11.4M K2 HealthVentures Equity Trust LLC May 9, 2025
BERNS PAUL L 5.1% $5.59M 8.23M Paul L Berns Dec 31, 2024
FMR LLC 2.2% $2.38M 3.5M FMR LLC Mar 31, 2025

Institutional Holders of Neumora Therapeutics, Inc. - Common Stock, $0.0001 par value (NMRA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 50.7M $92.3M -$7.65M $1.82 92
2025 Q2 56.1M $41.2M -$6.52M $0.73 96
2025 Q1 65.2M $65.2M -$163M $1.00 111
2024 Q4 80.3M $852M +$94.5M $10.60 132
2024 Q3 68.6M $906M +$20.3M $13.21 106
2024 Q2 63.8M $627M +$102M $9.83 93
2024 Q1 52.6M $724M +$113M $13.75 85
2023 Q4 43.7M $745M +$131M $17.05 60
2023 Q3 36.3M $511M +$511M $14.11 37